Safe Handling of Hazardous Drugs: Practical Considerations for Compounding and Administration

Faculty & Disclosures

Seth Eisenberg, RN, OCN®
Professional Practice Coordinator, Infusion Services
Seattle Cancer Care Alliance
Seattle, WA

Seth Eisenberg, RN, OCN® is the Professional Practice Coordinator for Infusion Services at the Seattle Cancer Care Alliance. He has been practicing in the field of oncology since 1983. He has held numerous posts within the Oncology Nursing Society (ONS), including Chemotherapy SIG Coordinator and SIG Council Chairperson; he is currently Contributing Editor for ONS Connect and a member of the ONCC Test Development Committee.

Seth has published articles in Nursing Clinics of North America, Oncology Nursing Forum, and the Journal of Infusion Nursing, among other journals. He was a coeditor for the NCI Chemotherapy and You booklet, and recently edited a chapter in the 2009 ONS Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. He has presented on a variety of topics at national conferences, including toxicities of high-dose chemotherapy, safe handling of chemotherapy, and vesicant extravasation.

Luci A. Power, MS, RPh
Senior Pharmacy Consultant
Power Enterprises
San Francisco, CA

Luci A. Power is an independent lecturer and consultant on pharmacy IV and hazardous drug systems. She was with the Department of Pharmaceutical Services at the University of California Medical Center in San Francisco for more than 25 years, serving in various capacities including Senior Pharmacist and Manager of the Parenteral Support Services. She was also Manager of the IV Additive Services, where she was responsible for the in-patient chemotherapy and other hazardous drug compounding. Luci received her bachelor's and master's degrees in pharmacy from Northeastern University College of Pharmacy in Boston, Massachusetts.

Luci is primary author of both the 1985 and 1990 American Society of Health-System Pharmacists (ASHP) Technical Assistance Bulletins on Handling Cytotoxic and Hazardous Drugs; lead author of the 2006 ASHP Guidelines on Handling Hazardous Drugs; and first author of the ASHP Safe Handling of Hazardous Drugs Video Training Program. Luci is an original member of the National Institute for Occupational Safety and Health (NIOSH) working group on hazardous drugs and an author of the 2004 NIOSH Alert: Preventing Occupational Exposures to Antineoplastics and Other Hazardous Drugs in Health Care Settings. Luci has done numerous presentations and publications on the safe handling of hazardous drugs in oncology practice.

Faculty Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.

Mr. Eisenberg and Ms. Power have reported that they have no significant financial or commercial relationships to disclose.

Program Information

Return to Safe Handling of Hazardous Drugs: Practical Considerations for Compounding and Administration

The material presented here does not reflect the views of Pharmacy Choice, Inc., ProCE, Inc., RxSchool, ICU Medical, Inc. or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.